These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 16093979

  • 1. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
    Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM.
    J Urol; 2005 Sep; 174(3):877-81. PubMed ID: 16093979
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
    Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Natl Cancer Inst; 2006 Aug 16; 98(16):1128-33. PubMed ID: 16912265
    [Abstract] [Full Text] [Related]

  • 4. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Clin Oncol; 2007 Jul 20; 25(21):3076-81. PubMed ID: 17634486
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman SM, Coltman CA.
    J Urol; 2007 Jul 20; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [Abstract] [Full Text] [Related]

  • 11. The influence of prostate volume on prostate-specific antigen performance: implications for the prostate cancer prevention trial outcomes.
    Elliott CS, Shinghal R, Presti JC.
    Clin Cancer Res; 2009 Jul 15; 15(14):4694-9. PubMed ID: 19584168
    [Abstract] [Full Text] [Related]

  • 12. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
    Cohen YC, Liu KS, Heyden NL, Carides AD, Anderson KM, Daifotis AG, Gann PH.
    J Natl Cancer Inst; 2007 Sep 19; 99(18):1366-74. PubMed ID: 17848668
    [Abstract] [Full Text] [Related]

  • 13. Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
    Punglia RS, Cullen J, McLeod DG, Chen Y, D'Amico AV.
    Cancer; 2007 Nov 01; 110(9):1973-8. PubMed ID: 17886252
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of finasteride on the percentage of free PSA: implications in the early diagnosis of prostatic cancer].
    Morote J, Lorente JA, Raventós CX, López MA, Encabo G, De Torres I, López M, De Torres JA.
    Actas Urol Esp; 1998 Nov 01; 22(10):835-9. PubMed ID: 9949572
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes.
    Lotan Y, Cadeddu JA, Lee JJ, Roehrborn CG, Lippman SM.
    J Clin Oncol; 2005 Mar 20; 23(9):1911-20. PubMed ID: 15774783
    [Abstract] [Full Text] [Related]

  • 19. The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
    Reed AB, Parekh DJ.
    Curr Opin Urol; 2009 May 20; 19(3):238-42. PubMed ID: 19318950
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.